New Study Shows Spironolactone Reduces Heart Failure Hospitalizations, But ... HealthCanal.com Boston, MA - A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18 ... AHA: Decision on Spironolactone in HF a Toss-Up? |
